Atlas Trials

Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans

Clinical trial NCT06940895 · COMPLETED

Trial details

NCT number
NCT06940895
Sponsor
Narrows Institute for Biomedical Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acanthosis Nigricans
Start date
2025-03-01
Primary completion
2025-07-08
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.